Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

http://www.wikidata.org/entity/Q37415839

about

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer Glycoproteins and glycoproteomics in pancreatic cancer C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma Immature truncated O-glycophenotype of cancer directly induces oncogenic features Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis.MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster.MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue.MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands.Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3 Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma.Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia.Presentation of underglycosylated mucin 1 in pancreatic adenocarcinoma (PDAC) at early stages.Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia.Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers.Nutrients and the Pancreas: An Epigenetic Perspective.Mucins in pancreatic cancer and its microenvironment.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Recent developments and applications of electron transfer dissociation mass spectrometry in proteomics.Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.The intestinal glycome and its modulation by diet and nutrition.Targeting cancer cell metabolism in pancreatic adenocarcinoma.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.Probing mucin interaction behavior of magnetic nanoparticles.Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.

P2860

Q26739942-323793EF-8857-42CB-A122-47738C0832FB Q26750872-DCCDAD66-03BF-4437-96B4-5CA813B293E6 Q28071108-E74ABDB2-2B41-4C99-93D8-D0CBFAD1B6E6 Q33999174-8D2DCAB1-4DF0-4FB1-9866-C37FD55F31BA Q34168525-B279F668-029D-4B94-B18D-4BF7E75A65CA Q34170367-12EA343F-D1DE-41FF-84D3-B8A35562EF3C Q34314283-C98CC739-36CA-43B5-B39F-F341281FFD5D Q34634961-CCB40727-264F-44E7-A9D4-04DB0C22B8BC Q34929956-9E1F4695-2DAD-4982-84B4-29BD8028EA01 Q35021578-E72787AD-8D67-4DAC-A713-C968269F7201 Q35034437-515D8A82-7075-4F75-B824-417887B652F8 Q35162645-348BF00C-8B07-4F2D-A200-7F7513E1A40D Q35551996-40016335-A9CA-4D43-A6E4-FB477B46965B Q35663610-5F04CBCC-671C-46C4-BAA9-298BAB2CF28F Q35686754-42F35EBB-5C9B-44BA-9571-23E693D13D61 Q35898801-D03077EF-E92A-42E6-B2CE-658D3710300F Q35899406-CD2E0A17-35BB-4A40-B998-3A40D2E7D576 Q36392717-98F193B2-4383-49F4-96FE-B139A8F1AE9B Q36546544-FCD06969-69CA-4800-8AEA-C1F40CD90D01 Q36833947-BD577F94-8843-4671-BF14-08217A74D273 Q37046734-313EAB00-7E41-4E2F-B40E-17CFA3A5C2C4 Q37047682-B20A31CE-1ABC-4B93-A6CD-437E7D9DD85D Q37273793-D4EB986B-8D6B-43C7-AD10-152CB114D921 Q37298294-AF72E780-88B7-4C46-A27D-ABA78758201B Q37343012-13D937D7-FC6F-479A-9514-0EE8064E6572 Q37510967-AD8B1DBB-BB25-4A74-AAA2-07F5CA3C3ABC Q37625192-6B410D1C-3D50-4D43-838B-C11274A11652 Q37636426-03CC41E4-56FC-4990-9266-98E63EAF96F1 Q37729841-067C573B-B60F-4065-9E6F-6F42FE3BF3A3 Q38121746-C67251B1-4AE2-427C-ACBE-EFFD7D510ED7 Q38162151-CB3545DC-25A3-4604-B6D9-40264E2CFC08 Q38200920-7681AE3C-F276-4AEA-BB43-B4A671E18761 Q38319885-DA994AF6-4EC8-490E-B4CA-A40076E9D9C0 Q38503059-278DBE79-192C-42DB-A5F7-50320DAA463A Q38545275-487BF593-511E-456C-9A98-DF826D6CA175 Q38608986-3CA2D8B6-BACE-4E24-9CA1-9996377F1229 Q38662233-720E3B38-3C24-4C35-9334-D0CCED2E68BA Q38691856-4BA90DC7-4B6C-4902-8D4A-6A2BE447F41E Q38731591-C1A61679-C1A1-44B6-82A2-BAC3BF637A74 Q38767655-0F11281D-0184-4D45-A920-693523D98440

P2860

Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

http://www.wikidata.org/entity/Q37415839

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@en

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@nl

type

label

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@en

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@nl

prefLabel

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@en

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@nl

P1433

Q37415839-DE69BE90-AB82-4C17-B71C-2C06E53C713C

P1476

Q37415839-3A1CECF1-FE56-4F07-845D-DFE127899113

P2093

Q37415839-230355C5-7AF1-466E-80F5-C1CCF0F03A13

Q37415839-5F1B5E98-1CD0-4DA9-A822-0A6C1B710342

Q37415839-61B93F37-A1A5-4211-99AF-087F657DADEE

Q37415839-7AD0127F-6D4B-4E39-AAC8-286D9D3028C0

Q37415839-94AFB21D-97E3-4417-B553-2366390AAD51

Q37415839-985715A0-E0D1-46E6-BA2A-6CC60269C27F

Q37415839-B4BD3E0E-7665-439A-9BEC-AFFB691F2E6E

Q37415839-D8A6A273-2024-4E76-BA37-6698BCE5E654

Q37415839-DA5C5AA4-C050-4A39-A7F5-5EEC7EA6D3A3

Q37415839-F516AC6F-3C91-41AB-ABB0-3200BF70B017

P2860

Q37415839-02821F29-9177-486A-8D81-2FA7B291A5F9

Q37415839-07B48A56-75BF-4601-90EE-5BF3DE30AB02

Q37415839-090633D9-E011-4A73-B92F-2306F94EF834

Q37415839-0AB64733-65CF-41EE-894F-7F5C28983D6E

Q37415839-1184C30E-2324-4E47-BB01-60BCD6D1DBD8

Q37415839-135D5736-ACB6-49D2-918A-6EA57B073EFE

Q37415839-1AFCB74C-B372-427B-8BB0-912E046DF797

Q37415839-24313AAB-DD9E-4AD3-9949-85DD8BFBA5B5

Q37415839-267BC579-F210-45FB-AEC0-9CA508A2852A

Q37415839-29D52C5D-94EC-4899-A0B1-C968798660AD

P304

Q37415839-4E06A5CB-0C42-4C0E-B00D-EBB60D8AE1B8

P31

Q37415839-7CA7136B-4C1A-4AFA-93E0-785E416E41E1

P356

Q37415839-7C5B9727-D1FB-48CE-8F02-8F1CB8AF83AF

P407

Q37415839-816429FB-FDE3-45A2-908C-02D8EB020911

P433

Q37415839-67EACE70-3456-441E-8484-9967C31B8E7B

P478

Q37415839-CF6C973B-CA96-4AB6-A1FA-B007BB090632

P577

Q37415839-4C79442B-BFC3-4C21-B7BD-DC32CA3C07F6

P698

Q37415839-8459534B-DDAD-428E-8726-E1257AE15AD8

P932

Q37415839-838FF70D-08A9-4AAE-8703-BE453FA4B6E3

P356

1078-0432.CCR-12-2662

P1433

Clinical Cancer Research

P1476

Aberrant expression of mucin c ...... gression of pancreatic cancer.

@en

P2093

Audrey J Lazenby

http://www.w3.org/2001/XMLSchema#string

Dominick J DiMaio

http://www.w3.org/2001/XMLSchema#string

Erin M Linde

http://www.w3.org/2001/XMLSchema#string

Fang Yu

http://www.w3.org/2001/XMLSchema#string

Hans H Wandall

http://www.w3.org/2001/XMLSchema#string

Henrik Clausen

http://www.w3.org/2001/XMLSchema#string

Judy M Anderson

http://www.w3.org/2001/XMLSchema#string

Michael A Hollingsworth

http://www.w3.org/2001/XMLSchema#string

Neeley Remmers

http://www.w3.org/2001/XMLSchema#string

Ulla Mandel

http://www.w3.org/2001/XMLSchema#string

P2860

Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

Mucins in cancer: function, prognosis and therapy

Modulation of MUC7 mucin expression by exogenous factors in airway cells in vitro and in vivo

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family

Mucins in cancer: protection and control of the cell surface

The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts

Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

P304

1981-1993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-12-2662

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23446997

http://www.w3.org/2001/XMLSchema#string

P932

3873635

http://www.w3.org/2001/XMLSchema#string